Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Maintaining optimal blood sugar levels is crucial for overall health and well-being. High or low blood sugar can lead to ...
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Incorporating heavy workout routines, strict diets, and taking countless pills can be tiring and not an optimal choice for ...
The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being received.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
The Bloomberg Industry Group has filed a legal action against a state agency challenging the transparency of an agreement to ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...